Data for: New-Onset Diabetes After Androgen-Deprivation Therapy For Prostate Cancer: A Nationwide Propensity Score-Matched Four-Year Longitudinal Cohort Study

Published: 14 Jun 2018 | Version 1 | DOI: 10.17632/693gg6gkd2.1

Description of this data

There is a strong link between long-term ADT and diabetes in prostate cancer patients. The association was particularly striking in the subgroup of patients receiving complete androgen blockade.

Most patients with prostate cancer die of conditions other than their primary cancer, including complications of ADT. Physicians should discuss with the patient in detail and inform the patient of the possible risk of ADT before starting treatment.

Experiment data files

peer reviewed

This data is associated with the following peer reviewed publication:

New-onset diabetes after androgen-deprivation therapy for prostate cancer: A nationwide propensity score-matched four-year longitudinal cohort study

Published in: Journal of Diabetes and Its Complications

Latest version

  • Version 1

    2018-06-14

    Published: 2018-06-14

    DOI: 10.17632/693gg6gkd2.1

    Cite this dataset

    Li, Ching Chia; Chou, Yii-Her; Yeh, Hsin-Chih; Wu, Wen-Jeng; Chang, Yu-Han; Guu, Shiao-Jin; Jhan, Jhen Hao (2018), “Data for: New-Onset Diabetes After Androgen-Deprivation Therapy For Prostate Cancer: A Nationwide Propensity Score-Matched Four-Year Longitudinal Cohort Study”, Mendeley Data, v1 http://dx.doi.org/10.17632/693gg6gkd2.1

Categories

Drug Therapy for Prostate Cancer

Mendeley Library

Organise your research assets using Mendeley Library. Add to Mendeley Library

Licence

CC BY 4.0 Learn more

The files associated with this dataset are licensed under a Creative Commons Attribution 4.0 International licence.

What does this mean?

This dataset is licensed under a Creative Commons Attribution 4.0 International licence. What does this mean? You can share, copy and modify this dataset so long as you give appropriate credit, provide a link to the CC BY license, and indicate if changes were made, but you may not do so in a way that suggests the rights holder has endorsed you or your use of the dataset. Note that further permission may be required for any content within the dataset that is identified as belonging to a third party.

Report